At Novartis, we are looking for social, technological and scientific-based solutions that shall allow greater efficiency in prevention, detection and control of Chagas and Malaria deseases in order to improve the quality of communities and people’s lives in Colombia.
Chagas is one of those vector-borne diseases of greatest importance in public health system throughout the country. According to the World Health Organization (WHO) there are approximately 438 000 infected people in Colombia (WHO). As for Malaria, approximately 12 million people live in risk areas in Colombia.
Create and drive ideas that increase effectiveness in Colombia related to prevention, early detection or access to treatments in risk areas where exist a lot of posibilities of getting Chagas and Malaria diseases; through the implementation of social, technological and scientific-based solutions.
Your project may provide one or several solutions from different stages and bases:
A total bag of up to 30,000 USD for the selected proposal(s)
Real time validation of a Minimum Viable Product, prototype or pilot model.
Social and relationship activities with potential beneficiaries.
Concerning the solutions in the phase of Scientific Research and/or those of Social Type; an accompaniment and support for a Colombian University will be done.
There will be done an accompaniment and support given by the organizer and allies to escalate and consolidate the entrepreneurship or solution selected in Colombia.
Proposals registration: October 3, 2019
Closure of the call for proposals: December 20, 2019
Official announcement of the selected proposal(s): April 2020
Follow-up and support of the project until: December 2020
Novartis is a Swiss company dedicated to improving and prolonging the quality of life of patients, through innovation and research. With more than 50 years in the Andean Region, the company sees innovation as one of its top priorities for the development of new medicines; In that sense, the commitment to the advancement of medicine is a constant in our work.